Efficacy Trial of a DNA/rAd5 HIV-1 Preventive Vaccine

Scott M. Hammer, Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Richard Novák(Illinois College), Richard A. Koup(Aaron Diamond AIDS Research Center), Barney S. Graham(National Institutes of Health), Chuka Anude(National Institute of Allergy and Infectious Diseases), Susan Buchbinder(University of California, San Francisco), James G. Kublin(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Georgia D. Tomaras(National Institutes of Health), Mary E. Enama(National Institutes of Health), Nicole Frahm(Fred Hutch Cancer Center), Carter Bentley(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Holly Janes(Fred Hutch Cancer Center), Lawrence Corey(Fred Hutch Cancer Center), Gary J. Nabel(National Institutes of Health), Beryl A. Koblin(New York Blood Center), Mark J. Mulligan(New York University), Shelly Karuna(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Ian Frank(Norwegian Womens Public Health Association), John R. Mascola(National Institute of Allergy and Infectious Diseases), M. Juliana McElrath(Fred Hutch Cancer Center), Magdalena E. Sobieszczyk(Columbia University Irving Medical Center), Elizabeth M. Adams(National Institutes of Health), Rong Fu(Fred Hutch Cancer Center), Edwin DeJesus(Orlando Immunology Center), John Hural(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Michael C. Keefer(University of Rochester Medical Center), Shelly Ramirez(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Doug Grove(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), David C. Montefiori(Duke University)
New England Journal of Medicine
October 7, 2013
Cited by 586


Related Papers